Chronic Periodontitis Clinical Trial
Official title:
Influence of Smoking on Fibroblast Apoptosis in Patients With Chronic and Aggressive Periodontitis
Apoptosis is an evolutionary form of physiological cell death. Studies suggest that
apoptosis is involved in the pathogenesis of periodontal diseases. Human gingival
fibroblasts (HGF) have an important role in the periodontal immune response. It is believed
that HGF can be diminished and/or eliminated by means of apoptosis.
Smoking is one of the most common risk factor of periodontal disease. Studies indicated that
smoking can increase the risk of periodontitis by enhancing the apoptosis of gingival
fibroblast.
The purpose of this study is to determine and to investigate apoptosis of HGF in gingival
biopsies collected from smokers and non smokers who are diagnosed with chronic periodontitis
or aggressive periodontitis.
Eighty subjects will be invited to participate in this study. Patients will be allocated
into four groups (20 patients each). Gingival biopsies will be obtained from the base of
papillae during surgical treatment (open flap curettage) and will be examined by
Immuno-histochemical analysis. Immune-staining will be done using p53 monoclonal mouse
anti-human antibody.
Background:
The mechanisms responsible for gingival tissue damage are poorly understood, and both
immune-mediated reactions and direct cytopathic effects of bacteria maybe involved. Based on
direct effect of bacteria in cell cultures, it has been suggested that apoptosis might play
an important role in periodontitis (Chen 1994).
Programmed cell death (apoptosis) is normal physiologic process that contributes to
maintaining tissue homeostasis. The process of apoptosis can be modulated by various stimuli
hormones, cytokines, growth factors, infections and immune-responses (Renehan et al. 2001).
Among other factors, the products of two genes that encode protein p53 and Bcl-2 have been
shown to play fundamental regulatory role in apoptosis. P53 is the protein product of
tumor-suppressor gene, and expression of P53 can induce apoptosis. This protein is also
implicated in the regulation of tissue dynamics, and is specifically thought to induce
apoptosis in terminally differentiated cells, including inflammatory cells (Bulut et
al.2006).
Fibroblast is a type of cell that synthesizes the extracellular and collagen in connective
tissue. It plays a critical role in wound healing. Fibroblasts are the most common cells in
connective tissue. The main function of fibroblasts is to maintain the structural integrity
of connective tissue by continuously secreting precursors of extracellular matrix. it was
reported that apoptosis levels increased in gingivitis and periodontitis (Jarenberg et al.
2002).
Cigarette smoking is a risk factor for many diseases, and recent evidence indicates that
smoking adversely influences periodontal health. A number of epidemiologic studies have
shown strong association between smoking and prevalence and severity of periodontitis
(Bostrom et al. 1998). Whereas, the pathogenesis of periodontitis in smokers is poorly
understood there are data suggesting that smoking effects on the periodontal tissues include
defects in neutrophil function, impaired serum antibody responses to periodontal pathogens,
and potentially diminished gingival fibroblast function (Shivanaikar et al. 2001). Smokers
are considered a high-risk group for periodontitis, and smoking history is a useful clinical
predictor of future disease activity (Hanokia et al. 2000).
Aims of the study:
- Investigation of the effects of smoking on fibroblasts apoptosis in smokers with
periodontitis compared to non-smokers with periodontitis using immuno-histochemical
methods.
- Comparison of apoptosis levels of gingival fibroblasts between chronic and aggressive
periodontitis.
Materials and methods:
A total of 80 subjects will be invited to participate in this study from the patients
referred to the Department of Periodontology, Faculty of Dentistry, University of Damascus.
The study will be approved by a specific Review Board. Subjects will be recruited according
to specific inclusion criteria after completion of medical and dental history
questionnaires. Patients will sign a consent form after being advised about the nature of
the study.
The selection of patients will be made according of the criteria approved by the 1999
international world workshop for a classification system of periodontal diseases and
conditions (Armitage 1999) using five clinical parameters and full mouth or panoramic
radiographs for diagnosis.
Subjects will be allocated into four groups:
- Smoking Chronic Periodontitis group (ChP-S): comprise 20 patients who are smokers and
aged > 45 years and have presence of ≥2 non-adjacent sites per quadrant that were not
first molars or incisors, with probing depth (PD) ≥5 mm, which bleed on gentle probing.
The demonstrated radiographic bone loss ≥30% of the root length, patient with poor oral
hygiene, the amount of accumulated plaque commensurate with the amount of clinical
attachment level (CAL)
- Non-smoking Chronic periodontitis group (ChP-NS): comprise 20 age-sex matched patients
who are non-smokers and have chronic periodontitis.
- Smoking Aggressive Periodontitis group (AgP-S): comprise 20 patients who are smokers
and aged < 35 years and diagnosed with rapid attachment loss with periodontal pocket
depth (PD) > 4 mm around at least three teeth other than the first molars and incisors.
Rapid bone destruction (>50%bone loss at diseased sites). Weak relationship between
dental plaque and the severity of gingival inflammation.
- Non-smoking Aggressive periodontitis group (AgP-NS): comprise 20 age- and sex matched
patients who are non-smokers and have aggressive periodontitis.
Clinical measurements:
A standard periodontal probe will be used for recording periodontal indices at six sites per
tooth. The examined clinical parameters include bleeding on probing (BOP), plaque index
(PI), clinical attachment loss (CAL) and periodontal pocket depth (PPD) and gingival index
(GI).
Biopsy collection and analysis
- The biopsy samples will be obtained from patients during surgical treatment (open flap
curettage) where biopsy is taken from the base area of papilla.
- Samples will be placed in 10% formalin.
- The samples will be then installed in paraffin wax.
- Samples will be analyzed in the by means of p53 monoclonal mouse anti-human antibody.
;
Observational Model: Case Control, Time Perspective: Cross-Sectional
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06400069 -
Role of NLRP6 in Chronic Periodontitis
|
||
Completed |
NCT05231096 -
Comparison of the Effect of Gingival Massage of Aloe-vera Gel and Sidr Honey on Chronic Periodontitis
|
N/A | |
Completed |
NCT03203746 -
Gingival Crevicular Fluid Levels of Protein Carbonyl Following the Use of Lycopene in Chronic Periodontitis
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03354338 -
Amoxicillin to Prevent Bacteria and Inflammatory Biomarkers After Intensive Periodontal Therapy
|
Phase 2 | |
Completed |
NCT02516111 -
Comparison of Autologous PRF, 1% Alendronate and 1.2% Atorvastatin Gel in Chronic Periodontitis Treatment
|
Phase 2/Phase 3 | |
Terminated |
NCT02568163 -
Influence of Stress on Non Surgical Periodontal Treatment
|
N/A | |
Completed |
NCT02174146 -
Leptin and Visfatin in Diabetic Patients With Periodontitis Before and After Periodontal Therapy
|
N/A | |
Completed |
NCT02430519 -
Benefits of Platelet Rich Fibrin In Mandibular Molar Furcation Defects
|
N/A | |
Completed |
NCT01233765 -
Analysis of Neutrophil Response in Chronic Periodontitis
|
N/A | |
Completed |
NCT01438333 -
Efficacy of INERSAN in Patients With Chronic Periodontitis as Adjunctive to Full Mouth Disinfection
|
N/A | |
Completed |
NCT02218515 -
Treatment of Intrabony Periodontal Defects With Enamel Matrix Derivatives and Autogenous Bone Graft
|
Phase 4 | |
Completed |
NCT02197260 -
Antimicrobial Therapy as Adjunct to Periodontal Treatment: Effect of Timing
|
Phase 4 | |
Not yet recruiting |
NCT03270280 -
Comparison of Salivary Interleukin-1β and Matrix Metalloproteinase-8 Levels in Individuals With Chronic Periodontitis
|
Phase 2 | |
Not yet recruiting |
NCT04026828 -
Evaluation of Possible Genes in Periodontal Diseases by Genetic Methods
|
||
Completed |
NCT04697199 -
The Adjunctive Effect of Probiotics to Non Surgical Treatment of Chronic Periodontitis
|
Phase 1 | |
Completed |
NCT04643288 -
Nanocrystalline Hydroxyapatite Bone Substitute for Treating Periodontal Intrabony Defects
|
N/A | |
Completed |
NCT03039244 -
Evaluation of Antimicrobial Photodynamic Therapy as an Adjunct to Periodontal Treatment in Smokers
|
N/A | |
Completed |
NCT02518152 -
Platelet Rich Fibrin+1% Alendronate in Treatment of Chronic Periodontitis
|
Phase 2/Phase 3 | |
Completed |
NCT03874390 -
Effects of Ozone Therapy on Clinical Parameters and Inflammatory Cytokines in Chronic Periodontitis Patients
|
N/A | |
Completed |
NCT02898675 -
Advantages of Autologous Platelet-Rich Fibrin Membrane on Growth Factor Levels and Periodontal Healing
|
N/A |